miR‐9 reduction resulted in increased expression of SASH1 and KRT13, already identified as miR‐9 targets in HNSCC cells (Citron et al,2017), and of the epithelial marker ZO‐1 (Fig 1B). Here, KRT13 is linked to head and neck squamous cell carcinoma.